FDA to manufacturers: Study suicide risks associated with medications
The Food and Drug Administration has announced it will require drug manufacturers to study correlation between medication and suicidal behavior during clinical trials.
According to a New York Times report, the manufacturers of drugs for such conditions as obesity, incontinence, depression, and more have been asked for the first time to study the psychiatric effects of their drugs during clinical trials.
The initial impetus for the change dates back four years, when it became clear that antidepressants could cause suicidal behavior in children and teenagers. Now it has come to the FDA's attention that classes of medications could come with the side effect of potential adverse psychiatric side effects. To read the full Times report, click here.
[ via Accreditation Connection ]
Recent Comments